23 May 2013
Keywords: sepracor, amends, xopenex, promotion, deal, ross, announced
Article | 29 March 2004
Sepracor has announced an amendment to its agreement with the Ross Products Division of Abbott Laboratories for the co-promotion of ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
29 March 2004
22 March 2004
15 March 2004
© 2013 thepharmaletter.com